Immunosuppressive Agents: all 5,940 studies that test it
Page 28 of 60. Open to participants first (674), then studies with results posted, then the rest; newest registration first within each.
- Cyclophosphamide, Abatacept, and Tacrolimus for the Prevention of GvHDActive, not recruitingNCT05621759Phase 2
- A First-In-Human Phase 1 Trial of T-Cell Membrane-Anchored Tumor Targeted Il12 (Attil12)- T-Cell Therapy in Subjects With Advanced/Metastatic Soft Tissue and Bone SarcomaActive, not recruitingNCT05621668Phase 1
- A Study Investigating Interactions Between BMS-986322 and Rosuvastatin, Metformin and Methotrexate in Healthy ParticipantsCompletedNCT05615012Phase 1
- Adjunctive Everolimus Treatment of Refractory EpilepsyStatus unknownNCT05613166Phase 2
- A Comparative Clinical Trial Evaluating the Effect and Safety of Tacrolimus Versus HydrocortisoneCompletedNCT05607901Phase 2
- Low-dose Interleukin-2 and Rapamycin on sjögren's SyndromeCompletedNCT05605665Phase 1/2
- Leflunomide Treatment for MEN1 Patients - the LUMEN1 TrialTerminatedNCT05605587Not applicable
- Belimumab for Treatment of cGVHD Following Allo-HCTWithdrawnNCT05604742Phase 1/2
- A Trial Comparing Unrelated Donor BMT With IST for Pediatric and Young Adult Patients With Severe Aplastic Anemia (TransIT, BMT CTN 2202)TerminatedNCT05600426Phase 3
- A Study to Evaluate Change in Disease Activity of Subcutaneous (SC) Epcoritamab Combined With Intravenous and Oral Rituximab, Cyclophosphamide, Doxorubicin Hydrochloride, Vincristine, and Prednisone (R-CHOP) or R-CHOP in Adult Participants With Newly Diagnosed Diffuse Large B-Cell Lymphoma (DLBCL)Active, not recruitingNCT05578976Phase 3
- Cladribine Combined With G-CSF and Cytarabine as a Salvage Treatment in R/R ALLStatus unknownNCT05578378Phase 2/3
- Anti-BCMA Chimeric Antigen Receptor T Cells for Relapsed or Refractory Multiple MyelomaActive, not recruitingNCT05577000Phase 1
- A Drug-drug Interaction Study to Evaluate the Effect of Rifampicin and Febuxostat on the Pharmacokinetics of Methotrexate in Healthy SubjectsCompletedNCT05575297Phase 1
- Efficacy of Ultrasound-Guided PRP Versus Corticosteroid Injection in Patients With Ulnar Neuropathy at ElbowCompletedNCT05567081Phase 2/3
- Orelabrutinib,Rituximab and Methotrexate in Newly-diagnosed Primary Central Nervous System Lymphoma(PCNSL)Status unknownNCT05549284Phase 2
- Using a Contact Dermatitis Model With Biologic Medications to Study Skin InflammationActive, not recruitingNCT05535738Phase 2/3
- MAD Study of IA-14069CompletedNCT05533372Phase 1
- Rapamycin Plus Methylprednisolone Versus Methylprednisolone Alone in Active, Moderate-to-severe Graves' Orbitopathy.Status unknownNCT05532072Early Phase 1
- Exploratory Study of Novel MSLN CAR-T Cell Therapy in Patients With MSLN-positive Advanced Refractory Solid TumorsWithdrawnNCT05531708Phase 1
- A Study of Thalidomide in the Treatment of Refractory Uremic PruritusStatus unknownNCT05525234Phase 4
- Methotrexate Combined With Immunotherapy During Radiotherapy for Solid TumorsActive, not recruitingNCT05522582Phase 2
- High-dose Chemotherapy+G-CSF in Peripheral Blood Stem Cell Mobilization in Patients With Multiple MyelomaCompletedNCT05517213Not applicable
- Novel CAR-T Cell Therapy in the Treatment of Hematopoietic and Lymphoid MalignanciesWithdrawnNCT05513612Phase 1
- Phase 1b Study of OP-1250 (Palazestrant) in Combination With Ribociclib, Alpelisib, Everolimus, or Atirmociclib in ER+, HER2- Breast CancerActive, not recruitingNCT05508906Phase 1
- A Study of Sirolimus for Injection (Albumin-bound) in Patients With Advanced Solid TumorsStatus unknownNCT05508620Phase 1
- An Open Label Trial Evaluating the Safety, Tolerability, Efficacy and Pharmacokinetic Profile of Tacrolimus Inhalation Powder in Adult Lung Transplant RecipientsTerminatedNCT05501574Phase 2
- To Evaluate the Efficacy of Toripalimab Combined With Chemotherapy After HIFU Induction in the Treatment of Early Triple-negative Breast CancerStatus unknownNCT05491694Phase 2
- Randomized Crossover of SVG101(Dispersible Tab. of Everolimus) and Afinitor 5mg in Healthy AdultsCompletedNCT05490095Phase 1
- Optimal Conditioning Regimen for Autologous Transplantation of Relapsing Remitting Multiple SclerosisWithdrawnNCT05482542Not applicable
- Cyclophosphamide and Dexamethasone for the Treatment of Metastatic Castration Resistant Prostate CancerActive, not recruitingNCT05479578Phase 1
- Suprachoroidal Triamcinolone Versus Posterior Subtenon Triamcinolone Alone or Formulated in the Management of Diabetic Macular Edema.CompletedNCT05464953Not applicable
- Mismatched Related Donor Versus Matched Unrelated Donor Stem Cell Transplantation for Children, Adolescents, and Young Adults With Acute Leukemia or Myelodysplastic SyndromeActive, not recruitingNCT05457556Phase 3
- Chemotherapy (DA-EPOCH+/-R) and Targeted Therapy (Tafasitamab) for the Treatment of Newly-Diagnosed Philadelphia Chromosome Negative B Acute Lymphoblastic LeukemiaActive, not recruitingNCT05453500Phase 2
- Efficacy and Safety of Abatacept Combined With JAK Inhibitor for Refractory Rheumatoid ArthritisStatus unknownNCT05451615Phase 3
- A Study to Assess the Effects of BMS-986371 on the Drug Levels of Methotrexate in the Presence and Absence of SulfasalazineCompletedNCT05445440Phase 1
- Topical SGX302 for Mild-to-Moderate PsoriasisCompletedNCT05442190Phase 2
- Precise Therapy for Refractory HER2 Positive Advanced Breast CancerStatus unknownNCT05429684Phase 3
- Thyroid Associated Orbitopathy Treatment by Methotrexate Against Triamcinolone Periocular InjectionsCompletedNCT05429450Phase 2
- Evaluation of the Effect of Narrowband UVB Versus Methotrexate on Serum Chitotriosidase Level in PsoriasisStatus unknownNCT05427175Phase 4
- RL-MPV Followed by BBC HCT Using Autologous Stem Cells and Maintenance Therapy With Nivolumab for Newly Diagnosed PCNSLStatus unknownNCT05425654Phase 2
- Corticosteroid Injection Combined With Cataract Surgery in Diabetic Eyes.CompletedNCT05413330Phase 2/3
- A Study of Zilovertamab Vedotin (MK-2140) in Combination With Cyclophosphamide, Doxorubicin, and Prednisone Plus Rituximab or Rituximab Biosimilar (Truxima) (R-CHP) in Participants With Diffuse Large B-Cell Lymphoma (DLBCL) (MK-2140-007)Active, not recruitingNCT05406401Phase 2
- R-MTX-zanbrutinib in Secondary CNS LymphomaStatus unknownNCT05398224Phase 2
- Tacrolimus Formulation and Glucose Metabolism After Kidney Transplantation (TAGLUMET Trial)CompletedNCT05396898Phase 4
- This Study Consists of Two Study Parts Conducted Under a Single IRB. Part I: Short Term ApoE-dependent Cerebral Blood Flow Response to Sirolimus in Cognitively Normal Adults Part II: Short Term ApoE-dependent Cerebral Blood Flow and Lung Perfusion Response to Sirolimus in Cognitively Normal AdultsActive, not recruitingNCT05386914Phase 1
- Formulated PSTA Injection Versus PATA Alone in the Management of Macular Edema Secondary to Non-ischemic Retinal Vein OcclusionsCompletedNCT05385562Not applicable
- A Clinical Trial of Safety and Tolerance of TQH3821 Tablets in Adult Healthy SubjectsCompletedNCT05380934Phase 1
- ......SMARTEST Trial......CompletedNCT05380713Phase 2
- Adding Itacitinib to Cyclophosphamide and Tacrolimus for the Prevention of Graft Versus Host Disease in Patients Undergoing Hematopoietic Stem Cell TransplantsActive, not recruitingNCT05364762Phase 2
- Addition of JSP191 (C-kit Antibody) to Nonmyeloablative Hematopoietic Cell Transplantation for Sickle Cell Disease and Beta-ThalassemiaActive, not recruitingNCT05357482Phase 1/2
- Methotrexate in Patients with Early Rheumatoid ArthritisActive, not recruitingNCT05353829Phase 4
- Cyclosporine 0.05% Eye Drops for Vernal Keratoconjunctivitis TrialCompletedNCT05353101Phase 1
- A Study to Evaluate Effect of IN-A001 on Pharmacokinetics of Tacrolimus in Healthy VolunteersStatus unknownNCT05353010Phase 1
- Efficacy of Formulated Posterior Sub Tenon Triamcinolone in Macular Edema Secondary to Non-Ischemic Retinal Vein OcclusionsCompletedNCT05345808Not applicable
- Novel Desensitization Kidney TransplantationCompletedNCT05345717Phase 1/2
- Daily Topical Rapamycin for VitiligoActive, not recruitingNCT05342519Phase 2
- Results of Suprachoroidal Steroids Injections in Two Chorioretinal DiseasesStatus unknownNCT05337332Phase 2/3
- Dropless Pars Plana Vitrectomy StudyCompletedNCT05331664Phase 4
- GM-CLAG in Relapsed/Refractory FLT3-mutated AMLWithdrawnNCT05330377Phase 1
- Study of Chidamide Combined With Cladribine in Refractory/Relapsed Acute Myeloid LeukemiaStatus unknownNCT05330364Phase 2
- Tacrolimus Versus Hydrocortisone in Atopic DermatitisCompletedNCT05324618Phase 4
- Orelabrutinib and Obinutuzumab Plus FC Regimen in Treating Newly Diagnosed CLL/SLLStatus unknownNCT05322733Phase 2
- A Study of the Drug IMGN632 in Children With Leukemia That Has Come Back After Treatment or is Difficult to TreatWithdrawnNCT05320380Phase 1/2
- Intralesional Versus Intramuscular Methotrexate for Non-melanoma Skin CancersCompletedNCT05315128Phase 2
- MTX Hold During Covid-19 BoosterStatus unknownNCT05313061Phase 3
- A Study to Evaluate Efficacy and Safety of Abatacept in Participants of Pemphigus Vulgaris (PV)Status unknownNCT05303272Phase 4
- Evaluation of 0.05% CsA and 0.1% FK506 Eye Drops in Ocular GVHD TreatmentCompletedNCT05294666Phase 4
- An Open Study on the Preventive Effect of Early Mizoribine Conversion on BKV Nephropathy in Renal Transplant RecipientsStatus unknownNCT05293704Phase 4
- Pharmacologic Pretransplant Immunosuppression (PTIS) + Reduced Toxicity Conditioning (RTC) Allogeneic Stem Cell Transplantation in Inherited Hematologic DisordersWithdrawnNCT05293509Phase 2
- Zanubrutinib Followed Zanubrutinib Plus FCR / BR in Newly Diagnosed Symptomatic CLL/SLLStatus unknownNCT05287984Phase 2
- Thiopurine Enhanced Mutations for PD-1/Ligand-1 EfficacyCompletedNCT05276284Phase 1/2
- Efficacy and Immunological Evaluation of Belimumab Plus Low Dose IL-2 in the Treatment of Systemic Lupus ErythematosusStatus unknownNCT05262686Phase 3
- A Phase IV Study of Safety and Efficacy of Everolimus in Taiwanese Patients With Tuberous Sclerosis Complex Who Have Renal Angiomyolipoma (TSC-AML)Active, not recruitingNCT05252585Phase 4
- Tetrandrine in the Treatment of Rheumatoid ArthritisStatus unknownNCT05245448Not applicable
- Maveropepimut-S (MVP-S) and Low-Dose CPA in Patients With Platinum-Resistant Ovarian CancerTerminatedNCT05243524Phase 2
- A Study of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Ulcerative ColitisActive, not recruitingNCT05242484Phase 2
- A Study of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Crohn's DiseaseActive, not recruitingNCT05242471Phase 2
- Tacrolimus Versus Mycophenolate for Autoimmune Hepatitis Patients With Incomplete Response on First Line TherapyStatus unknownNCT05221411Phase 4
- Efficacy and Safety Study of 4-Day ATG Regimen for Prophylaxis of aGVHD in Matched Sibling Donor PBSCTStatus unknownNCT05214066Phase 2
- Medical Treatment in Ectopic Tubal PregnancyCompletedNCT05208034Not applicable
- Drug-Drug Interaction (DDI) Study of ALXN2050 in Healthy Adult ParticipantsCompletedNCT05202145Phase 1
- A Phase II Study of Zanubrutinib, Lenalidomide Plus R-CHOP as the First-line Treatment for Diffused Large B-cell LymphomaStatus unknownNCT05200312Phase 2
- Antithymocyte Globulin as a Second Line Therapy in Graves OrbitopathyStatus unknownNCT05199103Not applicable
- Thalidomide Combined With Chemotherapy and Monotherapy for Maintenance Treatment for Her2-negative Advanced GCStatus unknownNCT05198856Phase 1/2
- AbataCept for the Treatment of Immune-cHeckpoint Inhibitors Induced mYocarditiSCompletedNCT05195645Phase 2
- Personalized DC Vaccines in Non Small Cell Lung CancerActive, not recruitingNCT05195619Phase 1
- Study to Compare the Efficacy and Safety After Conversion to RaparoBell® or My-Rept® in Kidney Transplant PatientsActive, not recruitingNCT05193565Phase 4
- Rapid Sequencing of Approved Therapies in Patients With Metastatic or Unresectable Clear Cell Renal Cell CarcinomaCompletedNCT05188118Early Phase 1
- A Feasibility Study to Evaluate the Tolerability of Oph1 Compared to Restasis in Healthy VolunteersCompletedNCT05184517Early Phase 1
- REduCed Dose of TNFi in Patients With Ankylosing SpondyliTis (RECAST)Status unknownNCT05164198Phase 4
- Effectiveness of Periocular Drug Injection in CATaract SurgeryTerminatedNCT05158699Phase 3
- Comparison of PT-Cy at a Dose of 25 mg/kg/Day and PT-Cy at a Dose of 50 mg/kg/Day in GVHD ProphylaxisStatus unknownNCT05158608Phase 3
- A Study in Healthy Adult Participants to Assess the Effects of Ciclosporin Administration on RilematovirCompletedNCT05155007Phase 1
- Efficacy and Safety of Belimumab in Neuromyelitis Optica Spectrum DisordersCompletedNCT05154734Phase 1/2
- A Study to Evaluate the Safety and Efficacy of a Modigraf® Based Immunosuppression Regimen in De Novo Pediatric Allograft Liver and Kidney Transplantation RecipientsCompletedNCT05153915Phase 4
- Everolimus Trial in Laryngotracheal StenosisCompletedNCT05153668Early Phase 1
- GvHD Prophylaxis in Unrelated Donor HCT: Randomized Trial Comparing PTCY Versus ATGActive, not recruitingNCT05153226Phase 3
- A Study of Modigraf® (Tacrolimus Granules) to Evaluate the Pharmacokinetics and Long-term Safety and Efficacy in De Novo Pediatric Allograft Liver and Kidney Transplantation RecipientsCompletedNCT05152628Phase 4
- Calcineurin Inhibitor in NEuRoloGically Deceased Donors to Decrease Kidney delaYed Graft Function (CINERGY)Active, not recruitingNCT05148715Phase 2
- A Phase 2 Study of Isatuximab in Combination With Bortezomib, Cyclophosphamide and Dexamethasone Followed by Isatuximab and Lenalidomide Maintenance in Newly Diagnosed Patients With Multiple Myeloma and Severe Renal ImpairmentStatus unknownNCT05147493Phase 2